Leaderboard

En | De
Sie sind hier: Endokrinologie » Schilddrüse 11. November 2024
Suchen
medline.ch
Schilddrüse
Erweiterte Suche
Dermatologie
Endokrinologie
Diabetes
Hypophyse
Nebenniere
Nebenschilddrüse
Schilddrüse
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 4060  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 81195  
   
Thyroid gland dysfunction and keratoconus.
Med Hypothesis Discov Innov Ophthalmol
Said OM, Iqbal M, El-Massry A, Elgharieb ME, Mady M, Sharawy AM, Abdelaziz K.
PMID: 39507808 [PubMed]


The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care.
Int J Cardiol Heart Vasc
Soetedjo NNM, Agustini D, Permana H.
PMID: 39507294 [PubMed]


Hyperthyroidism, hypothyroidism, thyroid stimulating hormone, and dementia risk: results from the NHANES 2011-2012 and Mendelian randomization analysis.
Front Aging Neurosci
Sheng X, Gao J, Chen K, Zhu X, Wang Y.
PMID: 39507203 [PubMed]


Postoperative Bleeding Risk in Thyroid Surgery: Differences between Conventional and Endoscopic Video-Assisted Neck Surgery Methods.
J Nippon Med Sch
Saitou M, Akasu H, Jikuzono T, Sen M, Kazusaka H, Matsui M, Sugitani I.
PMID: 39505500 [PubMed - indexed for MEDLINE]


Médecine nucléaire et cancers de la thyroïde en 2024 : iode 131, TEP et nouvelles approches théranostiques.
Bull Cancer
Ciappuccini R, Nascimento C, Edet-Sanson A, Bardet S.
PMID: 39505438 [PubMed - indexed for MEDLINE]


La prise en charge des cancers médullaires de la thyroïde en 2024.
Bull Cancer
Lasolle H, Borson-Chazot F, Gauduchon T, Haissaguerre M, Illouz F, Lifante JC, Lussey-Lepoutre C, Prunier D, Sajous C, Varnier R, Hadoux J.
PMID: 39505437 [PubMed - indexed for MEDLINE]


Nouveautés en pathologie thyroïdienne : classification OMS 2022, système Bethesda 2023, biologie moléculaire et testing moléculaire.
Bull Cancer
Bani MA, Moog S, Suciu V, Lamartina L, Ghuzlan AA.
PMID: 39505436 [PubMed - indexed for MEDLINE]


Quelles avancées dans la prise en charge du carcinome anaplasique de la thyroïde en 2024 ?
Bull Cancer
Jannin A, Lugat A, Escande A, Godbert Y, Wasserman J, Cao CD, Hadoux J.
PMID: 39505435 [PubMed - indexed for MEDLINE]


Le cancer thyroïdien différencié réfractaire à l’iode : quelle prise en charge en 2024 ?
Bull Cancer
Cao CD, Danais A, Schwartz P, Godbert Y.
PMID: 39505434 [PubMed - indexed for MEDLINE]


Prise en charge des cancers thyroïdiens localisés de souche vésiculaire différenciée.
Bull Cancer
Lamartina L, Grunenwald S, Roy M, Hartl D, Buffet C.
PMID: 39505432 [PubMed - indexed for MEDLINE]


National trends in thyroid disease and COVID-19 pandemic-related factors, 1998-2021: A nationwide representative study in South Korea.
Heliyon
Lee K, Park J, Lee M, Lee H, Son Y, Kim H, Kang J, Choi Y, Rhee SY, Rahmati M, Koyanagi A, Smith L, López Sánchez GF, Dragioti E, Woo S, Yon DK.
PMID: 39502207 [PubMed]


Contrast-Enhanced Ultrasound for Diagnosing Thyroid Nodules With Indeterminate Cytology: A Retrospective Study.
Clin Endocrinol (Oxf)
Liu Y, Liu H, Zhan J, Chai Q, Zhu J, Ding S, Chen L.
PMID: 39502003 [PubMed - as supplied by publisher]


Diagnostic significance of ultrasound characteristics in discriminating follicular thyroid carcinoma from adenoma.
BMC Med Imaging
Xu R, Wen W, Zhang Y, Qian L, Liu Y.
PMID: 39501175 [PubMed - indexed for MEDLINE]


A digital pathology model for predicting radioiodine-avid metastases on initial post-therapeutic (131)I scan in patients with papillary thyroid cancer.
Sci Rep
Xue Y, Zheng M, Wu X, Li B, Ding X, Liu S, Liu S, Liu Q, Gao Y.
PMID: 39500984 [PubMed - indexed for MEDLINE]


Polycystic Ovary Morphology, Subclinical Hypothyroidism, and the Cutoff Value of Thyroid-Stimulating Hormone, a Population-Based Study.
Reprod Sci
Nazarpour S, Mousavi M, Ramezani Tehrani F.
PMID: 39500847 [PubMed - as supplied by publisher]


SATB2 is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series with Comprehensive Biomarker and Molecular Studies.
Endocr Pathol
Nkosi D, Crowe WE, Altman BJ, Oltvai ZN, Giampoli EJ, Velez MJ.
PMID: 39499447 [PubMed - as supplied by publisher]


Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis.
Ann Nucl Med
Xue Y, Zhang Y, Ding X, Wu X, Li B, Zhang Y, Gao Y.
PMID: 39499416 [PubMed - as supplied by publisher]


The role of external-beam radiotherapy for differentiated thyroid cancer.
Jpn J Clin Oncol
Kawamoto T, Shikama N, Nakamura N, Mizowaki T.
PMID: 39498757 [PubMed - as supplied by publisher]


Application of composite reference intervals in the diagnosis of subclinical hypothyroidism in the elderly: a retrospective study.
PeerJ
Li P, Yang W, Tang G, Li Z.
PMID: 39498291 [PubMed - indexed for MEDLINE]


Coagulation-related genes for thyroid cancer prognosis, immune infltration, staging, and drug sensitivity.
Front Immunol
Sun Y, Zhang Y, Yang Y, Liu W, Yin D.
PMID: 39497824 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 81195    Seite 1 von 4060  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1